Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J company Ethicon Endo-Surgery buys medical device firm SterilMed for undisclosed terms
Yahoo/AP
Wednesday, September 28, 2011 - 11:32am
tags:
JNJ, Ethicon-Endo Surgery, M&A, SterilMed
Amgen and the Supremes: Did the CEO Know About a Kickback Scheme?
BNET Pharma
Wednesday, September 28, 2011 - 9:21am
tags:
Supreme Court, Amgen, Epogen, Kevin Sharer, kickbacks, Aranesp
Astellas halts development of anti-clotting drug
Reuters
Wednesday, September 28, 2011 - 9:19am
tags:
Astellas, YM150, anti-clotting
The Wisdom Of The Crowds And Sangamo's Phase II B Clinical Trial Results
Seeking Alpha
Wednesday, September 28, 2011 - 9:17am
tags:
Sangamo BioSciences, SB-509, diabetic neuropathy
Novartis' Respiratory Ambitions Are On Track
Seeking Alpha
Wednesday, September 28, 2011 - 9:16am
tags:
Novartis, NVA237, COPD
[video]Tranzyme CEO: We Were Lucky to Go Public
TheStreet.com
Wednesday, September 28, 2011 - 9:15am
tags:
Tranzyme, Pharma CEOs, Vipin Gurg, IPOs
Novartis Drug Afinitor May Be A Blockbuster Breast Cancer Treatment
Seeking Alpha
Tuesday, September 27, 2011 - 7:33pm
tags:
breast cancer, Novartis, Afinitor
Merck, Sanofi’s Gardasil Beats Glaxo’s Rival Vaccine on Cost
Bloomberg
Tuesday, September 27, 2011 - 7:32pm
tags:
HPV, Gardasil, vaccines, Sanofi, GSK, Cervarix
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tuesday, September 27, 2011 - 7:31pm
tags:
Bristol-Myers Squibb, Orencia, MDX-1106, BMS-936558, Ono Pharmaceutical
J&J's Doxil Woes Show Shortages Aren't Easily Fixed
Motley Fool
Tuesday, September 27, 2011 - 7:26pm
tags:
Doxil, JNJ, drug shortages, cancer
No consolation for Sanofi as Genzyme scrambles
Fierce Pharma
Tuesday, September 27, 2011 - 12:02pm
tags:
Genzyme, Sanofi
Tianyin Pharmaceuticals' Management Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, September 27, 2011 - 12:00pm
tags:
earnings, Tianyin Pharmaceutical
Will the FDA Yank Bayer’s Risky Birth-Control Pill Yaz?
BNET Pharma
Tuesday, September 27, 2011 - 11:59am
tags:
Bayer, birth control pill, FDA, Yaz, Yasmin
Pens Vs. Payments In Pharmaceutical Marketing
Forbes
Tuesday, September 27, 2011 - 11:53am
tags:
physician payments
Why Pharma Stocks Can Rise Before Trial Results
Pharmalot
Tuesday, September 27, 2011 - 11:39am
tags:
clinical trials, drug stocks
Are You Watching This Trend at Illumina?
Motley Fool
Tuesday, September 27, 2011 - 11:38am
tags:
Illumina, Complete Genomics, Qiagen, Life Technologies
When 'Accelerated' FDA Reviews Are Slow
TheStreet.com
Tuesday, September 27, 2011 - 11:26am
tags:
FDA, Marqibo, leukemia, Talon Therapeutics
ImmunoGen CEO on New Breast Cancer Drug
CNBC
Tuesday, September 27, 2011 - 11:23am
tags:
breast cancer, Immunogen, T-DM1
Is GlaxoSmithKline Working Hard Enough for You?
Motley Fool
Tuesday, September 27, 2011 - 11:21am
tags:
GSK
Gates-Backed Fund to Buy $1 Billion of Glaxo, Pfizer Shots
Bloomberg
Tuesday, September 27, 2011 - 11:21am
tags:
Bill Gates, GSK, Pfizer, philanthropy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.